Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol

Journal of Clinical Psychiatry

Volumn 65, Issue 1, 2004, Pages 57-61

  Volavka, Jan ^a,b,g   Czobor, Pal ^a,b   Cooper, Thomas B ^a,b   Sheitman, Brian ^c,d   Lindenmayer, Jean Pierre ^a,b   Citrome, Leslie ^a,b   McEvoy, Joseph P ^e,f   Lieberman, Jeffrey A ^d  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Dorothea Dix Hospital   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e John Umstead Hospital   (United States)

^f DUKE UNIVERSITY   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; RISPERIDONE;

ADULT; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SEXUAL DYSFUNCTION;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; PROLACTIN; RISPERIDONE; SCHIZOPHRENIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 1442357994     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0109     Document Type: Article

References (18)

1. Chou JCY, Douyon R, Czobor P, et al. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder. Psychiatry Res 1998;81:51-55 (Pubitemid 28494170)
2. Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975;188:1217-1219
3. Zhang XY, Zhou DF, Yuan CL, et al. Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia. Psychiatry Res 2002;109:297-302 (Pubitemid 34311986)
4. Breier AF, Malhotra AK, Su T-P, et al. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry 1999;156:294-298 (Pubitemid 29077121)
5. Markianos M, Hatzimanolis J, Lykouras L. Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone. Psychopharmacology (Berl) 1999;143:270-272 (Pubitemid 29204980)
6. Tollefson GD, Kuntz AJ. Review of recent clinical studies with olanzapine. Br J Psychiatry Suppl 1999;37:30-35 (Pubitemid 29089309)
7. David SR, Taylor CC, Kinon BJ, et al. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther 2000;22:1085-1096 (Pubitemid 30747129)
8. Markianos M, Hatzimanolis J, Lykouras L. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol. Eur Arch Psychiatry Clin Neurosci 2001;251:141-146 (Pubitemid 32963107)
9. Kleinberg DL, Davis JM, de Coster R, et al. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999;19:57-61 (Pubitemid 29047332)
10. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
11. Chouinard G, Ross-Chouinard A, Annable L, et al. Extrapyramidal Symptom Rating Scale [abstract]. Can J Neurol Sci 1980;7:233
12. Volavka J, Czobor P, Sheitman B, et al. Clozapine, olanzapine, risperidone, and haloperidol in treatment-resistant patients with schizophrenia and schizoaffective disorder. Am J Psychiatry 2002;159:255-262 (Pubitemid 34126903)
13. Sinha YN, Selby FW, Lewis UJ, et al. A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab 1973;36:509-516
14. Le Moing JP, Edouard S, Levron JC. Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1993;614:333-339 (Pubitemid 23142091)
15. Catlow JT, Barton RD, Clemens M, et al. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr B: Biomed Appl 1995;668:85-90
16. Bianchetti G, Morselli PL. Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorus selective detection. J Chromatogr 1978;153:203-209 (Pubitemid 8347621)
17. Simpson GM, Cooper TA. Clozapine plasma levels and convulsions. Am J Psychiatry 1978;135:99-100 (Pubitemid 8261136)
18. Citrome L, Volavka J. Optimal dosing of atypical antipsychotics in adults: a review of the current evidence. Harv Rev Psychiatry 2002;10:280-291